• Assessment of Cost-Effectiveness Models for Biologics in the Management of Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Dos Formulaciones De Toxina Botulínica Tipo a (TBA) En Colombia Para El Tratamiento De La Parálisis Cerebral Infantil (PCI)

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis (CMA) of Different Strategies to Treat Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Cost Effectiveness Evaluation of a Rotavirus Vaccination Program in Argentina

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer in Kazakhstan

    Nov 1, 2013, 00:00

  • Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast Cancer

    Nov 1, 2013, 00:00

  • Comparison Retail Prices of Drug Prices Between Turkey and European Countries

    Nov 1, 2013, 00:00

  • Medical Costs of Patients with Rheumatoid Arthritis and Association with Global Disease Activity in Turkey

    Nov 1, 2013, 00:00

  • La Protección Financiera Y El Gasto De Bolsillo En Salud De La Población Mexicana 2002-2010

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Multiple Sclerosis in Slovakia

    Nov 1, 2013, 00:00

  • Comparing Health-Related Quality of Life Across Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis- Analyses from Certolizumab Pegol Clinical Trial Baseline Data

    Nov 1, 2013, 00:00

  • Cost-Utility of First-Line Adalimumab and Tocilizumab Monotherapies in Rheumatoid Arthritis Based on Head-To-Head Data

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of an Interface Geriatric Intervention- Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study (AMIGOS)

    Nov 1, 2013, 00:00

  • Pregnancy After Breast Cancer in 2000-2002 and 2010-2012- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • Unmet Needs and Biologic Use Among Patients with Rheumatoid Arthritis in Brazil

    Nov 1, 2013, 00:00

  • Crescimento De Óbitos Pós Partos Cesarianos No Brasil Versus Partos Normais

    Nov 1, 2013, 00:00

  • Estimation of the Number of Cases of Nosocomial Pneumonia in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico

    Nov 1, 2013, 00:00

  • Comparing Quality of Life and Clinical Variables for the Prediction of Future Medical Events

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Measurement of Fatigue Using Modified Fatigue Impact Scale

    Nov 1, 2013, 00:00

  • Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal Products

    Nov 1, 2013, 00:00

  • Assessment of Burden of Illness Due to Herpes Zoster in Argentina- A Prospective Observational Study

    Nov 1, 2013, 00:00

  • Defining Standards of Clinician Qualifications for the Linguistic Validation of Clinical Outcome Assessments (COAs)

    Nov 1, 2013, 00:00

  • Lost in Translation- Translatability of Psychiatric Terms – The Example of the Mini–International Neuropsychiatric Interview (M.I.N.I.)

    Nov 1, 2013, 00:00

  • Análisis Comparativo De Insulina Glargina Frente a Insulina Detemir- Modelo De Minimización De Costos Para Colombia

    Nov 1, 2013, 00:00

  • Validating an Indolent Non-Hodgkin’s Lymphoma (NHL) Cost-Effectiveness Analysis Model Using Two Software Tools- Key Implementation Considerations and Results

    Nov 1, 2013, 00:00

  • A Cost-Of-Illness Analysis of Hepatitis C in Greece

    Nov 1, 2013, 00:00

  • Pharmacotherapy Costs of Multiple Myeloma in the Czech Republic- A Retrospective Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Plerixafor (PXF) for Stem Cell Mobilization in Lymphoma (NHL/HL) and Multiple Myeloma (MM) Patients in Poland

    Nov 1, 2013, 00:00

  • Economic Evaluation of Enhanced Asthma Management- A Systematic Review

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Antidepressant After 24 Months of Treatment Based on Discrete Event Simulation Modeling (DESM)- Agomelatine Versus Matrix Comparator of Escitalopram, Sertraline and Venlafaxine in a Thai Setting

    Nov 1, 2013, 00:00

  • Are Patients’ Preferences for Osteoporosis Drug Treatment Transferable Between Countries? Results from a Discrete-Choice Experiment Conducted in Two European Countries

    Nov 1, 2013, 00:00

  • Structural Failure Time Modeling of Overall Survival Effects in Oncology Trials with Subsequent Therapies

    Nov 1, 2013, 00:00

  • Second-Line Treatment of Metastatic Colorectal Cancer (mCRC)- A Systematic Literature Review (SLR) and Feasibility Assessment of Conducting Indirect Treatment Comparison (ITC) Analysis

    Nov 1, 2013, 00:00

  • Trastuzumabe No Câncer De Mama Metastático- Uma Revisão Sistemática De Análises Custo-Efetividade

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Routine Gentamicin-Collagen Implants for the Prevention of Surgical Site Infection (SSI) in High Risk Cardiothoracic Surgery Patients

    Nov 1, 2013, 00:00

  • Benchmarks for Interpretation of Score Differences on the SF-36 Health Survey for Patients with Diabetes

    Sep 1, 2013, 00:00

  • Erratum

    Sep 1, 2013, 00:00

  • Cost-Utility of Metal-on-Metal Hip Resurfacing Compared to Conventional Total Hip Replacement in Young Active Patients with Osteoarthritis

    Sep 1, 2013, 00:00

  • Table of Contents

    Sep 1, 2013, 00:00

  • Economic Assessment of an Anti-HCV Screening Program in Italy

    Sep 1, 2013, 00:00

  • Priority Preferences: “End of Life” Does Not Matter, But Total Life Does

    Sep 1, 2013, 00:00

  • Complete Cytogenetic Response and Major Molecular Response as Surrogate Outcomes for Overall Survival in First-Line Treatment of Chronic Myelogenous Leukemia- A Case Study for Technology Appraisal on the Basis of Surrogate Outcomes Evidence ...

    Sep 1, 2013, 00:00

  • The Cloudy Crystal Ball of Cost-Effectiveness Studies

    Sep 1, 2013, 00:00

  • Improving Model Validation in Health Technology Assessment- Comments on Guidelines of the ISPOR-SMDM Modeling Good Research Practices Task Force

    Sep 1, 2013, 00:00

  • Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort

    Sep 1, 2013, 00:00

  • Early Scientific Advice Obtained Simultaneously from Regulators and Payers- Findings from a Pilot Study in Australia

    Sep 1, 2013, 00:00

  • Item-Level Psychometric Properties for a New Patient-Reported Psoriasis Symptom Diary

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States

    Sep 1, 2013, 00:00

  • Economic Incentives for Evidence Generation- Promoting an Efficient Path to Personalized Medicine

    Sep 1, 2013, 00:00

  • Editorial Board

    Sep 1, 2013, 00:00

  • Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Functional Assessment of Cancer Therapy-Cognitive in Asian Patients With Breast Cancer

    Sep 1, 2013, 00:00

  • ISPOR-SMDM Task Force’s Recommendations for Good Modeling Practices—Reply to Letter to the Editor by Corro Ramos

    Sep 1, 2013, 00:00

  • Health State Valuation in Low- and Middle-Income Countries- A Systematic Review of the Literature

    Sep 1, 2013, 00:00

  • Modeling SF-6D Hong Kong Standard Gamble Health State Preference Data Using a Nonparametric Bayesian Method

    Sep 1, 2013, 00:00

  • Reflections on Market Access for Personalized Medicine- Recommendations for Europe

    Sep 1, 2013, 00:00

  • Value-Based Assessment of Pharmacodiagnostic Testing from Early Stage Development to Real-World Use

    Sep 1, 2013, 00:00

  • Copyright/Subscription

    Sep 1, 2013, 00:00

  • Genetic Screening for the Predisposition to Venous Thromboembolism- A Cost-Utility Analysis of Clinical Practice in the Italian Health Care System

    Sep 1, 2013, 00:00

  • Treatment Dynamics of Newly Marketed Drugs and Implications for Comparative Effectiveness Research

    Sep 1, 2013, 00:00

  • Title Page

    Sep 1, 2013, 00:00

  • Exploring the Consistency of the SF-6D

    Sep 1, 2013, 00:00

  • Regulation, Reimbursement, and the Long Road of Implementation of Personalized Medicine—A Perspective from the United States

    Sep 1, 2013, 00:00

  • Editorial Board

    Sep 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Trial of Labor After Cesarean in the United States

    Sep 1, 2013, 00:00

  • Instructions for Authors

    Sep 1, 2013, 00:00

  • Program-Specific Cost-Effectiveness Analysis- Breast Cancer Screening Policies for a Safety-Net Program

    Sep 1, 2013, 00:00

  • Copyright/Subscription

    Sep 1, 2013, 00:00

  • Advancing Pediatric Patient-Reported Outcome Assessment

    Sep 1, 2013, 00:00

  • The Development and Validation of a Multidimensional Sum-Scaling Questionnaire to Measure Patient-Reported Outcomes in Acute Respiratory Tract Infections in Primary Care- The Acute Respiratory Tract Infection Questionnaire

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Baseline Low-Dose Computed Tomography Screening for Lung Cancer- The Israeli Experience

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas—Author Response to Letter to the Editor

    Sep 1, 2013, 00:00

  • Instructions for Authors

    Sep 1, 2013, 00:00

  • Personalized Medicine and the Role of Health Economics and Outcomes Research- Issues, Applications, Emerging Trends, and Future Research

    Sep 1, 2013, 00:00

  • Responsiveness of the Testing Morbidities Index in Colonoscopy

    Sep 1, 2013, 00:00

  • Table of Contents

    Sep 1, 2013, 00:00

  • PHP97 Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions

    Jul 1, 2013, 00:00

  • Development and Initial Validation of the NCCN/FACT Symptom Index for Advanced Kidney Cancer

    Jul 1, 2013, 00:00

  • Validating and Improving the Reliability of the EORTC QLQ-C30 Using a Multidimensional Rasch Model

    Jul 1, 2013, 00:00

  • Deciding Which Drugs Get Onto the Formulary- A Value-Based Approach

    Jul 1, 2013, 00:00

  • Gastroprotective Strategies in Chronic NSAID Users- A Cost-Effectiveness Analysis Comparing Single-Tablet Formulations with Individual Components

    Jul 1, 2013, 00:00

  • Table of Contents

    Jul 1, 2013, 00:00

  • Efficacy, Patient-Reported Outcomes (PROs), and Tolerability of the Changing Therapeutic Landscape in Patients with Metastatic Prostate Cancer (MPC)- A Systematic Literature Review

    Jul 1, 2013, 00:00

  • How Should We Value Future Health? Was NICE Right to Change?

    Jul 1, 2013, 00:00

  • Value of Research and Value of Development in Early Assessments of New Medical Technologies

    Jul 1, 2013, 00:00

  • How Should We Deal with Patient Heterogeneity in Economic Evaluation- A Systematic Review of National Pharmacoeconomic Guidelines

    Jul 1, 2013, 00:00

  • Reviewing the Evidence to Inform the Population of Cost-Effectiveness Models within Health Technology Assessments

    Jul 1, 2013, 00:00

  • Italian Population-Based Values of EQ-5D Health States

    Jul 1, 2013, 00:00

  • Editorial Board

    Jul 1, 2013, 00:00

  • Compensation Mechanisms for Lost Productivity- A Comparison between Four European Countries

    Jul 1, 2013, 00:00

  • Transarterial Chemoembolization Treatment- Association between Multiple Treatments, Cumulative Expenditures, and Survival

    Jul 1, 2013, 00:00

  • Copyright/Subscription

    Jul 1, 2013, 00:00

  • Willingness to Pay for Diagnostic Technologies- A Review of the Contingent Valuation Literature

    Jul 1, 2013, 00:00

  • Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation- Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force

    Jul 1, 2013, 00:00

  • Association between Health-Related Quality of Life and Body Mass After Adjustable Gastric Banding- A Nonlinear Approach

    Jul 1, 2013, 00:00

  • Health Utility Assessment Using EQ-5D among Caregivers of Children with Autism

    Jul 1, 2013, 00:00

  • Economic Analysis of the Intangible Impacts of Informal Care for People with Alzheimer’s Disease and Other Mental Disorders

    Jul 1, 2013, 00:00

  • Does the Process of Deliberation Change Individuals’ Health State Valuations? An Exploratory Study Using the Person Trade-Off Technique

    Jul 1, 2013, 00:00

  • Where Are We on “Risk-Sharing” Agreements?

    Jul 1, 2013, 00:00

  • Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer

    Jul 1, 2013, 00:00

  • Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey

    Jul 1, 2013, 00:00

  • A Systematic Literature Review of Psychosocial and Behavioral Factors Associated with Initial Medication Adherence- A Report of the ISPOR Medication Adherence Persistence Special Interest Group

    Jul 1, 2013, 00:00

  • Updating the Canadian Hemophilia Outcomes–Kids Life Assessment Tool (CHO-KLAT Version2.0)

    Jul 1, 2013, 00:00

  • Which Is More Valuable, Longer Survival or Better Quality of Life? Israeli Oncologists’ and Family Physicians’ Attitudes Toward the Relative Value of New Cancer and Congestive Heart Failure Interventions

    Jul 1, 2013, 00:00

  • Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension- A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group

    Jul 1, 2013, 00:00

  • Instructions for Authors

    Jul 1, 2013, 00:00

  • Cost-Effectiveness of Early Assisted Discharge for COPD Exacerbations in The Netherlands

    Jun 1, 2013, 00:00

  • Table of Contents

    Jun 1, 2013, 00:00

  • Copyright/Subscription

    Jun 1, 2013, 00:00

  • Authors’ Response to “Comparative Effectiveness and Personalized Medicine” by Dr. J.C. Hornberger

    Jun 1, 2013, 00:00

  • Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data—Recommendations for Clinical Trial Teams- Report of the ISPOR ePRO Systems Validation Good Research Practices Task Force

    Jun 1, 2013, 00:00

  • Examining Item Content and Structure in Health Status and Health Outcomes Instruments- Toward the Development of a Grammar for Better Understanding of the Concepts Being Measured

    Jun 1, 2013, 00:00

  • Using a Survey to Estimate Health Expectancy and Quality-Adjusted Life Expectancy to Assess Inequalities in Health and Quality of Life

    Jun 1, 2013, 00:00

  • QALY and Productivity Loss- Empirical Evidence for “Double Counting”

    Jun 1, 2013, 00:00

  • Comparative Effectiveness in Personalized Medicine—Clearly Defining the Intended Use Population

    Jun 1, 2013, 00:00

  • Probability Elicitation to Inform Early Health Economic Evaluations of New Medical Technologies- A Case Study in Heart Failure Disease Management

    Jun 1, 2013, 00:00

  • Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation

    Jun 1, 2013, 00:00

  • Instructions for Authors

    Jun 1, 2013, 00:00

  • Measuring the Quality of a Childhood Cancer Care Delivery System- Quality Indicator Development

    Jun 1, 2013, 00:00

  • Measuring the Quality of a Childhood Cancer Care Delivery System- Assessing Stakeholder Agreement

    Jun 1, 2013, 00:00

  • The Mental Component of the Short-Form 12 Health Survey (SF-12) as a Measure of Depressive Disorders in the General Population- Results with Three Alternative Scoring Methods

    Jun 1, 2013, 00:00

  • Assessing the Value of Symptom Relief for Patients with Gastroesophageal Reflux Disease Treatment- Willingness to Pay Using a Discrete Choice Experiment

    Jun 1, 2013, 00:00

  • Editorial Board

    Jun 1, 2013, 00:00

  • Radical Cystectomy versus Bladder-Preserving Therapy for Muscle-Invasive Urothelial Carcinoma- Examining Confounding and Misclassification Biasin Cancer Observational Comparative Effectiveness Research

    Jun 1, 2013, 00:00

  • ePRO Systems Validation- Clearly Defining the Roles of Clinical Trial Teams and ePRO System Providers

    Jun 1, 2013, 00:00

  • Systematic Searching and Selection of Health State Utility Values from the Literature

    Jun 1, 2013, 00:00

  • Value of Information Analysis from a Societal Perspective- A Case Study in Prevention of Major Depression

    Jun 1, 2013, 00:00

  • Digitization of Patient-Reported Outcomes

    Jun 1, 2013, 00:00

  • Computer Modeling of Diabetes and Its Complications- A Report on the Fifth Mount Hood Challenge Meeting

    Jun 1, 2013, 00:00

  • Cost-Effectiveness of Trabectedin Plus Pegylated Liposomal Doxorubicin for the Treatment of Women with Relapsed Platinum-Sensitive Ovarian Cancer in the UK- Analysis Based on the Final Survival Data of the OVA-301 Trial

    Jun 1, 2013, 00:00

  • Estimating the Effectiveness of HPV Vaccination in the Open Population- A Bayesian Approach

    Jun 1, 2013, 00:00

  • Using Whole Disease Modeling to Inform Resource Allocation Decisions- Economic Evaluation of a Clinical Guideline for Colorectal Cancer Using a Single Model

    Jun 1, 2013, 00:00

  • Evaluating the Cost-Effectiveness of Diagnostic Tests in Combination- Is It Important to Allow for Performance Dependency?

    Jun 1, 2013, 00:00

  • Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling- Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force

    Jun 1, 2013, 00:00

  • A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data- Report of the ISPOR Oncology Good Outcomes Research Practices Working Group

    Jun 1, 2013, 00:00

  • Reporting of Patient-Reported Outcomes in Randomized Trials- The CONSORT PRO Extension

    Jun 1, 2013, 00:00

  • Meta-Analysis of the Accuracy of Two Diagnostic Tests Used in Combination- Application to the Ddimer Test and the Wells Score for the Diagnosis of Deep Vein Thrombosis

    Jun 1, 2013, 00:00

  • Illustrating Potential Efficiency Gains from Using Cost-Effectiveness Evidence to Reallocate Medicare Expenditures

    Jun 1, 2013, 00:00

  • Health-Related Quality of Life of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes—Results from the PLATO Trial

    Jun 1, 2013, 00:00

  • Cost-Saving Measures In Reimbursement Of Orphan Drugs Under Medicare Prescription Drug Plans

    May 1, 2013, 00:00

  • Comparative efficacy and safety of treatments for the management of overactive bladder- A systematic literature review and mixed treatment comparison

    May 1, 2013, 00:00

  • Generic quality of life burden of multiple sclerosis as compared to other debilitating chronic conditions

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis Of Using Levonorgestrel-Releasing Intrauterine System In Long-Term Contraception In Colombia

    May 1, 2013, 00:00

  • Trends in attention deficit hyperactivity disorder medication use and expenditures in the united states- An analysis of 2000-2010 medical expenditure panel data

    May 1, 2013, 00:00

  • Economic Burden Of Adverse Events In Patients Aged ≥65 Years Receiving Treatment For Metastatic Renal Cell Carcinoma (Mrcc)

    May 1, 2013, 00:00

  • Comparison of commercial insurance databases to census data for age, gender and geographic region in the united states

    May 1, 2013, 00:00

  • An Estimate Of The Health Economic Burden Of Unsatisfactory Cervical Cancer Screening Test Samples In A Population Of Women Between The Ages Of 21-65 Years In The United States

    May 1, 2013, 00:00

  • Relationship between major bleeding and concurrent use of antiplatelet drugs with chinese medications

    May 1, 2013, 00:00

  • Costs associated with intravenous patient controlled analgesia (IV-PCA) in us hospitals

    May 1, 2013, 00:00

  • Preliminary Study On Development Of Budget Impact Analysis Guidelines In Korea- The Comparison Of Guidelines On Budget Impact Analysis For Health Technologies

    May 1, 2013, 00:00

  • The value of a good decision- Assessing the economic benefits of decision aids

    May 1, 2013, 00:00

  • Clinical Characteristics, Quality Measure Attainment, And Diabetes-Related Health Care Costs In Elderly Versus Overall People Living With Type-2 Diabetes Mellitus (T2dm) Receiving Metformin (Met) And Sulfonylurea (Su)

    May 1, 2013, 00:00

  • Age And Gender Distribution Of Outpatient Care Physiotherapy Services For Traumatic Injuries In Hungary

    May 1, 2013, 00:00

  • Characteristics of adult medicaid beneficiaries with schizophrenia treated with paliperidone palmitate and predictors of treatment continuity

    May 1, 2013, 00:00

  • Effect of statins in delaying the progression of diabetic kidney disease- Systematic review of randomized controlled trials

    May 1, 2013, 00:00

  • Systematic literature review of the temporal relationship between nsaid use and gastrointestinal, cardiovascular, or renal events

    May 1, 2013, 00:00

  • A cost-effectiveness analysis of transcatheter aortic-valve implantation (TAVI) compared to medical management for severe aortic stenosis in Colombia

    May 1, 2013, 00:00

  • Breast Cancer Patients Receiving Guideline-Concordant Adjuvant Therapy Regimens Have Better All-Cause And Disease-Specific Survival- New Findings From Rural Georgia

    May 1, 2013, 00:00

  • Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL)

    May 1, 2013, 00:00

  • DRG system in Italy- Evaluation Of Different Reimbursements For Surgical Procedures At National, Regional And Hospital Level

    May 1, 2013, 00:00

  • Potential Medical Cost Savings Associated With Routine Hospital-Based Use Of A Rapid Diagnostic Tool For Bloodstream Infection In The United States

    May 1, 2013, 00:00

  • Impact of treatment persistence on health care charges among opioid-dependent patients treated with buprenorphine / naloxone- 2006-2012 insurance claims retrospective analysis in the United States

    May 1, 2013, 00:00

  • Patient-centered outcomes in late-stage oncology indications – are manufacturers focusing on the patient?

    May 1, 2013, 00:00

  • Parents' Expectation To Receive Antibiotic Prescription For Children

    May 1, 2013, 00:00

  • Translatability Assessment Of The Youth Quality-Of-Life Instrument–Weight Module (YQOL-W)

    May 1, 2013, 00:00

  • Methodological challenges in the estimation of the incidence rate of rare diseases from specialized centers- Lessons learned from a study of multicentric castleman's disease

    May 1, 2013, 00:00

  • Survival Of Patients With Advanced Melanoma In A Real World Setting

    May 1, 2013, 00:00

  • Quality Of Life In Rheumatoid Arthritis- How Much Do We Really Know?

    May 1, 2013, 00:00

  • Comparative analysis of direct cost studies on rheumatoid arthritis in Turkey

    May 1, 2013, 00:00

  • Reset research of traditional chinese medicine syndrome angina questionnaires

    May 1, 2013, 00:00

  • The Burden Of Glaucoma And Its Complications- A Large Population-Based Cohort Study

    May 1, 2013, 00:00

  • Minimally Invasive Cosmetic Procedures- Patient Motivation And Satisfaction

    May 1, 2013, 00:00

  • Clinical outcome of flouoro-2,deoxy-glucose positron emmission tomography/ computed tomography [FDG PET/CT] in breast cancer patients- study based on its refferal pattern

    May 1, 2013, 00:00

  • The Relationship Between Local Family Physician Supply And Population Health Status In The Federal Regions In The United States

    May 1, 2013, 00:00

  • Estimation of long-term care needs in patients under maintenance hemodialysis

    May 1, 2013, 00:00

  • Economic Analysis Of The Mexican's Institute For Social Security (IMSS) Expenditure

    May 1, 2013, 00:00

  • Impact of dosage strength on medication persistence among patients treated with buprenorphine transdermal system

    May 1, 2013, 00:00

  • The Impact Of Prostate Cancer On Quality Of Life

    May 1, 2013, 00:00

  • How can we use discrete event simulation to improve access to health care- an assessment of increasing access to care for children with medically refractory epilepsy

    May 1, 2013, 00:00

  • Clinical and economic assesment of the effectiveness of entecavir in comparison with pegylated interferon, lamivudine, telbivudine, tenofovir in treatment of chronic viral hepatitis in Russian federation

    May 1, 2013, 00:00

  • Estimating Development Cost Of An Interactive Website Based Cancer Screening Promotion Program

    May 1, 2013, 00:00

  • Challenges In Developing An Outcome Measures Framework For Patient Registries

    May 1, 2013, 00:00

  • Knowledge, Belief And Attitude Of General Practitioners In Prescribing Antibiotics For Upper Respiratory Tract Infections

    May 1, 2013, 00:00

  • The Relationship Between Nurse Staffing And Patient Satisfaction In Emergency Departments

    May 1, 2013, 00:00

  • Impact Of Severe And Very Severe Chronic Obstructive Pulmonary Disease (Copd) On Health-Related Quality Of Life (Hrqol) And Work Productivity- Results Of A Nationally Representative Patient Survey And Chart Review Of Recently Exacerbating P ...

    May 1, 2013, 00:00

  • Comprehension Of Copd-Specific Terminology In Translated Patient Reported Outcomes Questionnaires

    May 1, 2013, 00:00

  • Cost Of Metastatic Castration-Resistant Prostate Cancer In The United States

    May 1, 2013, 00:00

  • Different Stakeholder Perspectives On Pharmacogenomic Testing

    May 1, 2013, 00:00

  • Variances in the rate of face, internal, and third party model validity by type of publication, type of model, and geographic region

    May 1, 2013, 00:00

  • The Impact Of Patient Protection And Affordable Care Act Regulations On Drug Manufacturers' Medicaid Market Segment Profitability

    May 1, 2013, 00:00

  • A review of cardiovascular disease health state utilities reported in cost-utility analyses 2000 – 2010

    May 1, 2013, 00:00

  • Do asians have similar health-state preference? A study of mainland chinese and singaporeans

    May 1, 2013, 00:00

  • Examining the rate of myocardial infarction and associated costs in patients concomitantly receiving clopidogrel and various ppis- A retrospective claims analysis

    May 1, 2013, 00:00

  • Comparative effectiveness of smoking cessation medications among obese smokers

    May 1, 2013, 00:00

  • Attitudes Towards The Role Of Community Pharmacists In Iraq

    May 1, 2013, 00:00

  • Impact of velaglucerase alfa on quality of life of adult patients with type-i gaucher disease

    May 1, 2013, 00:00

  • Disease Burden Of Idiopathic Chronic Cough (Icc) And Chronic Cough (Cc) In Copd, Ipf And Lung Cancer (Lc)- An Exploratory Literature Review

    May 1, 2013, 00:00

  • Importance, Anticipated Burden, And Function- Validity Of Utilities For Impotence And Urinary Incontinence

    May 1, 2013, 00:00

  • Penicillin and amoxicillin prophylaxis in children with sickle cell disease (SCD)- compliance and cost comparison

    May 1, 2013, 00:00

  • Hospitalizations among bipolar disorder patients before and after initiating lurasidone in a commercially insured population

    May 1, 2013, 00:00

  • Prioritization Of In Vitro Diagnostic Tests For Updating Health Coverage In Colombia

    May 1, 2013, 00:00

  • Social Networks Boost Diabetes Education And Reduce Hba1c And Blood Sugar

    May 1, 2013, 00:00

  • Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia

    May 1, 2013, 00:00

  • Disparities In Influenza Vaccinations Among Community Pharmacy Users And Non-Users

    May 1, 2013, 00:00

  • Influence of pharmacist mediated medication counseling on medication adherence behavior in hypertensive patients at a south indian tertiary care teaching hospital

    May 1, 2013, 00:00

  • Effect of body mass index (BMI) on yearly medical and non-medical costs in an employee population using generalized additive regression models

    May 1, 2013, 00:00

  • Economic evaluation of using branded taxotere® versus. generic docetaxel- Based on decision tree model

    May 1, 2013, 00:00

  • Health care fraud 2006 to 2011

    May 1, 2013, 00:00

  • Impact of initiating statin therapy at a high dose – A retrospective observational study populations in the United Kingdom

    May 1, 2013, 00:00

  • Role Of Subgroup Analyses For Health Technology Assessments

    May 1, 2013, 00:00

  • Diabetes and severity of coronary artery disease- assessment of clinical, epidemiologic, and angiographic characteristics

    May 1, 2013, 00:00

  • Testing the construct validity of the icecap-o as a measure of capability in frail older people

    May 1, 2013, 00:00

  • Type 2 Diabetes Patient Characteristics By Race/Ethnicity

    May 1, 2013, 00:00

  • Prevelance Of Pulmonary Tuberculosis And Multi Drug Resistant Tuberculosis Patients In Baghdad, Iraq

    May 1, 2013, 00:00

  • Identifying accurate patient-based health and social care costs of older people for trial-based economic evaluation- Is it really worth it?

    May 1, 2013, 00:00

  • Cost-Effectiveness Evaluation Of Amphotericin B, Amphotericin B Liposomal, Caspofungin And Voriconazol In Treating Aspergillosis Under The Brazilian Public Health Care System Perspective

    May 1, 2013, 00:00

  • Determining Economic Impact Of A Pharmacist-Led It-Based Intervention With Simple Feedback In Reducing Rates Of Clinically Important Errors In Medicines Management In General Practices (PINCER)

    May 1, 2013, 00:00

  • Economic Outcomes Associated With Hba1c And Ldl-C Goal Achievement In Patients With Type 2 Diabetes Mellitu

    May 1, 2013, 00:00

  • Economic evaluations of antiretroviral therapy monitoring using routine hiv viral load testing in low-income settings- A systematic review

    May 1, 2013, 00:00

  • A comparison of outcomes in clinical trials conducted within the united states versus outside the united states

    May 1, 2013, 00:00

  • Determining the cost of a bleeding-related episode in primary adult chronic immune thrombocytopenia (ITP) in the United States

    May 1, 2013, 00:00

  • Caregiver burden and social support in families of children with autism- A literature review

    May 1, 2013, 00:00

  • Review of cost-utility analyses in Asia

    May 1, 2013, 00:00

  • Cost-effectiveness of atypical antipsychotics as treatment for patients with bipolar disorder (episodes of mania)- A comparison between quetiapine, aripiprazole, olanzapine, risperidone and ziprasidone in the Russian health care

    May 1, 2013, 00:00

  • Systematic Literature Review Of Costs Related To Patients With Type-2 Diabetes Mellitus Experiencing A Stroke Or Myocardial Infarction

    May 1, 2013, 00:00

  • Pharmaceutical Spending Levels Across Europe – Consequences Of Current International Pricing Policies On Lower Income Countries

    May 1, 2013, 00:00

  • Public Engagment Mechanisms In Health Technology Assessment (HTA)- An Early Assessment Of Canada's National HTA Public Engagement Initiatives

    May 1, 2013, 00:00

  • A systematic review on the quality of pharmacoeconomics studies in China

    May 1, 2013, 00:00

  • Thirty-day complications following bariatric surgery

    May 1, 2013, 00:00

  • The Effect Of Audit On The Quality Of The Referral Process In The Upper East Region Of Ghana

    May 1, 2013, 00:00

  • Time-specific propensity score analysis for observational study- A case study estimating the effectiveness of thiazolidinedione use

    May 1, 2013, 00:00

  • A European Assessment Of The Impact Of Inadequate Pain Relief (Ipr) On Health-Related Quality Of Life (Qol) In Patients With Knee Osteoarthritis (Oa) In The Survey Of Real World Therapies (Sort)

    May 1, 2013, 00:00

  • Epidemiologic transition of hepatitis a in six countries and implications for vaccination policy- Data from a systematic literature review

    May 1, 2013, 00:00

  • The Health And Economics Bulletin – An Analysis Of Four Years Of Publication

    May 1, 2013, 00:00

  • Continued Declines In Mortality Are Largely Due To Reductions In Non-Aids Related Deaths, And Mortality Remains Disproportionately Higher Among Blacks And The Publicly Insured In The Hiv Outpatient Study (Hops), 1996–2009

    May 1, 2013, 00:00

  • Hidden barriers to delivery of pharmacologic venous thromboembolism prophylaxis- The role of nursing beliefs and practices

    May 1, 2013, 00:00

  • Longitudinal changes in health-related quality of life for chronic diseases- An example from the hemophilia utilization group study part va (HUGS Va)

    May 1, 2013, 00:00

  • Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients

    May 1, 2013, 00:00

  • The patient perception of intensity of urgency scale (PPIUS)- Its validation in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

    May 1, 2013, 00:00

  • Public health impact and cost effectiveness of hepatitis a vaccination in the united states- A population-based dynamic model

    May 1, 2013, 00:00

  • The Association Of Dementia With Time To Hospitalizations- Is There A Need For Disease Management?

    May 1, 2013, 00:00

  • Trends in the cost and charges for a hospital admission for acute ischemic stroke (AIS) in the united states- do the trends track with the consumer price index (CPI) for medical care services?

    May 1, 2013, 00:00

  • Cost–Effectiveness Of A Mailed Advance Notification Letter To Increase Colorectal Cancer Screening

    May 1, 2013, 00:00

  • Cost Per Treated Patient For Biologics In Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis And Ankylosing Spondylitis Using Claims Data

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Efavirenz Compared With Generic Nevirapine In Hiv Patients Initiating First-Line Treatment In The United States

    May 1, 2013, 00:00

  • Direct and indirect costs among us employees with and without bipolar disorder or schizophrenia- Annual cost trends from 2001 to 2011

    May 1, 2013, 00:00

  • Assessing The Implementation Of Nice Guidan Is There A Correlation Between Recommendations And Uptake In Clinical Practice?

    May 1, 2013, 00:00

  • Geographic variation in diagnosis, medication use and associated costs of attention deficit disorder (ADD)

    May 1, 2013, 00:00

  • A cost-minimization analysis of a new fixed-dose combination of dutasteride and tamsulosin compared to concomitant administration of both monotherapies for the treatment of symptomatic benign prostatic hyperplasia in Quebec, Canada

    May 1, 2013, 00:00

  • Determinants Of Physician Practice Styles

    May 1, 2013, 00:00

  • Physician's adherence to the 2009 AHA/ACC guidelines in acute myocardial infarction (AMI) in cardiac care unit of a private tertiary health care setting in Northern India

    May 1, 2013, 00:00

  • Use Of Anti-Infectives For Systemic Administration In Serbia In 2011

    May 1, 2013, 00:00

  • Predictors Of Successful Smoking Cessation Among Smokers Who Made Quit Attempts During The Previous Year

    May 1, 2013, 00:00

  • Patient-Reported Severe Hypoglycemic Event Rate In National Health And Wellness Survey

    May 1, 2013, 00:00

  • Patient preferences for therapies in Epilepsy

    May 1, 2013, 00:00

  • How much is fatigue associated with anemia

    May 1, 2013, 00:00

  • Drug treatment patterns for the management of men with benign prostatic hyperplasia (BPH) who have predominant urgency and frequency symptoms in uk primary care the health improvement network (THIN) data

    May 1, 2013, 00:00

  • Acute bacterial skin and skin structure infections (ABSSSI) signs/ symptoms and pros- A comprehensive literature review

    May 1, 2013, 00:00

  • Assesing parameter importance in health economics models. Can we make it faster?

    May 1, 2013, 00:00

  • Analysis Of The Waxman-Hatch Act Pharmaceutical Patent Extensions (1984–2012)

    May 1, 2013, 00:00

  • Prevalence of thyroid disorders and need for universal screening of thyroid dysfunction in pregnant women- A meta-analysis

    May 1, 2013, 00:00

  • Comparison of two methods for identifying problematic opioid use among an opioid-treated chronic pain population

    May 1, 2013, 00:00

  • Approaches to pain management among older and younger adults experiencing moderate to severe pain in a national health survey- Too much or not enough?

    May 1, 2013, 00:00

  • Transformation Of Services And Care Pathway Redesign In The NHS- Further Reforms In Health Policy

    May 1, 2013, 00:00

  • A comparison of biphasic insulin aspart (biasp30) with biphasic human insulin (bhi30) for type 2 diabetes mellitus in real clinical practice – A systematic review and meta-analysis

    May 1, 2013, 00:00

  • Designing corresponding assessments for children and parents to improve data capture in special populations

    May 1, 2013, 00:00

  • Evaluation of clinical and treatment characteristics and the economic burden of anxiety in veteran patients in the United States

    May 1, 2013, 00:00

  • Drug Interactions In Elderly Population In Primary Health Care

    May 1, 2013, 00:00

  • Adherence To Therapy Among Diabetes Patients In A Niger Delta Referral Center

    May 1, 2013, 00:00

  • Complete Drug Information, A Key For Safe Therapy- A Comparative Evaluation Of Drug Brochures Used For Disseminating Drug Information By Pharmaceutical Companies In Pakistan And Malaysia

    May 1, 2013, 00:00

  • Expanding concepts of opioid-taking behavior in sickle cell disease- A multi-phase, mixed methods study

    May 1, 2013, 00:00

  • Modeling And Analytics Framework For Value Based Pricing

    May 1, 2013, 00:00

  • Nonadherence And Treatment Interruption Of Tyrosine Kinase Inhibitors Association With Health Care Resource Cost And Utilization In Chronic Myeloid Leukemia Patients

    May 1, 2013, 00:00

  • Medical, Drug, And Work-Loss Costs Of Venous Leg Ulcers

    May 1, 2013, 00:00

  • Medication Utilization To Antidepressants Among Dual Eligibles Before And After Part D

    May 1, 2013, 00:00

  • Observed Abiraterone Acetate Utilization By Prostate Cancer (Pc) Patients In A Large Administrative Claims Database In The United States

    May 1, 2013, 00:00

  • Utility Values For Specific Chronic Myelogenous Leukaemia (Cml) Chronic Phase Health States Elicited From The General Public In The United Kingdom

    May 1, 2013, 00:00

  • Predictors and correlates of health related quality of life in a hypertensive population of Pakistan

    May 1, 2013, 00:00

  • Treatment Modalities For Hepatocellular Carcinoma- Cumulative Expenditures And Survival In Seer-Medicare

    May 1, 2013, 00:00

  • Homeless Patients Use Of Urban Emergency Departments In The United States

    May 1, 2013, 00:00

  • Translation and linguistic validation of the facit-dyspnea for use with patients experiencing dyspnea worldwide

    May 1, 2013, 00:00

  • Oral Antidiabetic Use Among Nursing Home Residents With Diabetes And Moderate To Severe Chronic Kidney Disease

    May 1, 2013, 00:00

  • Impact Of Opioid-Induced Constipation- A Multinational Cross-Sectional Survey Of Patients And Health Care Providers

    May 1, 2013, 00:00

  • Reconciling Variations In Propensity Score Matching (PSM) Algorithms In Observational Comparative Effectiveness Research (OCER)

    May 1, 2013, 00:00

  • Treatment Of Asthma Using Ics/Laba Drugs Pre- And Post-Label Change

    May 1, 2013, 00:00

  • Systematic Literature Review Of Utilities Relating To Patients With Type-2 Diabetes Mellitus Experiencing A Stroke Or Myocardial Infarction

    May 1, 2013, 00:00

  • Adjusting For Inflation In Economic Evaluations Of Health Technologies- Are We Doing It Wrong?

    May 1, 2013, 00:00

  • Using A Validated Algorithm To Evaluate The Effectiveness Of Biologics For Rheumatoid Arthritis In A Commercial Claims Database

    May 1, 2013, 00:00

  • Linguistic validation in multiple patient populations- Cognitive interviewing approaches

    May 1, 2013, 00:00

  • A Retrospective Study On The Burden Of Cytomegalovirus Disease In Immunosuppressed Persons Following Transplantation Between 2007 And 2011 In France

    May 1, 2013, 00:00

  • Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems

    May 1, 2013, 00:00

  • Stated time-allocation, adherence, and health-outcome tradeoff preferences in cystic fibrosis households

    May 1, 2013, 00:00

  • Systematic literature review and meta-analysis of B-cell therapies in systemic lupus erythematosus

    May 1, 2013, 00:00

  • The pain assessment for lower back symptoms (PAL-S)- Qualitative development and cognitive evaluation of a new patient reported outcome measure for the assessment of low back pain

    May 1, 2013, 00:00

  • Factors Associated With Initiation Of Testosterone Replacement Therapy In Aging Males

    May 1, 2013, 00:00

  • Impact Of Place Of Delivery On Neonatal Mortality In Rural Tanzania

    May 1, 2013, 00:00

  • The Effect Of FDA Risk Evaluation Mitigation Strategies On Utilization Of Selected Drugs Using Data From Two National Surveys

    May 1, 2013, 00:00

  • PRE-Marketing Authorization Of New Medical Devices In The European Union And The United States

    May 1, 2013, 00:00

  • Indirect costs of schizophrenia for community-dwelling texas residents

    May 1, 2013, 00:00

  • Propensity score analysis in MEPS 2003-2010- PCS and MCS scores after migraine treatments

    May 1, 2013, 00:00

  • A conjoint analysis to evaluate attribute choices and feature trade-offs in otc analgesic product purchase

    May 1, 2013, 00:00

  • Modeling Future Prevalence Of Neurological Conditions And Demand For Pharmaceuticals In The United States

    May 1, 2013, 00:00

  • Prescribing Pattern Of Clinicians In Private Health Facilities- An Assessment For Rational Drug Use

    May 1, 2013, 00:00

  • Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Infliximab Versus Colectomy For The Treatment Of Severe Active Ulcerative Colitis In Poland

    May 1, 2013, 00:00

  • EVALUATING THE COST OF OPIOID DEPENDENCE TREATMENT MODELS IN EUROPE

    May 1, 2013, 00:00

  • Assessment of drug related problems (DRP) in prescriptions received by patients suffering from chronic diseases dwelling in a south indian rural community

    May 1, 2013, 00:00

  • Disease burden of atrial fibrillation, Colombia 2000-2009

    May 1, 2013, 00:00

  • Network meta-analysis of longitudinal data

    May 1, 2013, 00:00

  • Evaluation Of Asthma-Related Pharmacy Quality Alliance (Pqa) Measures In The Mississippi Medicaid Population

    May 1, 2013, 00:00

  • Outpatient Visits For Schizophrenia In The United States- A Nationally Representative Analysis Using Namcs And NHAMES Data

    May 1, 2013, 00:00

  • Impact Of Comparative Effectiveness Research On Biomedical Innovation And Population Health

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Vaginal Progesterone Gel In Reducing Preterm Birth- A Decision Analytic Model Based On The Pregnant Randomized Clinical Trial

    May 1, 2013, 00:00

  • Investigating Rational Use Of Prescription Drugs In Saudi Ministry Of Health Hospitals Using World Health Organization Level-Ii Indicators; Does The Pharmacy And Therapeutics Committee Have An Impact?

    May 1, 2013, 00:00

  • Issues In The Selection Of Comparators For Regulatory And Hta Submissions

    May 1, 2013, 00:00

  • The development and validation of a revised version of the medical outcomes study cognitive functioning scale (MOS-COG-R)

    May 1, 2013, 00:00

  • Impact Of South Carolina's Prescription Drug Monitoring Program On The Use Of Benzodiazepines In A Commercially Insured Population

    May 1, 2013, 00:00

  • Does device matter and at what cost? real-world comparative study of insulin glargine treatment using disposable pen versus vial/syringe in medicaid patients with type-2 diabetes mellitus

    May 1, 2013, 00:00

  • Agency Agreement In Health Technology Assessment Reimbursement Decisions

    May 1, 2013, 00:00

  • Demographic and clinical characteristics, and treatment of cardiovascular risk factors among U.S. elderly patients with high-risk vascular disease

    May 1, 2013, 00:00

  • Evaluating the average reinterventions, reintervention costs and total costs for a heparin-bonded eptfe stent-graft in patients with atherosclerotic disease of the SFA

    May 1, 2013, 00:00

  • Sensitivity And Specificity Of A Quality Of Life Questionnaire Qualeffo-41

    May 1, 2013, 00:00

  • Generating utility values for use in cost-utility analyses of delirium interventions

    May 1, 2013, 00:00

  • Reemphasizing The Economics In Pharmacoeconomics

    May 1, 2013, 00:00

  • Identification of patients at high risk for subsequent development of atrial fibrillation or stroke using a claims database

    May 1, 2013, 00:00

  • Observational Ustekinumab Dosing Paradigm In Psoriasis- Evidence Of Step-Up And Step-Down Events

    May 1, 2013, 00:00

  • Novel Electronic Patient Reported Outcomes Tool For Prostate Cancer Patients

    May 1, 2013, 00:00

  • Multi-Payers Comparison Of Daily Reimbursement Values Of Distinct Hospital Facilities In The Brazilian Private Health System

    May 1, 2013, 00:00

  • Assessment Of Patients' Knowledge Of Drug Therapy In A Nigerian Health Care Facility

    May 1, 2013, 00:00

  • Comparison between the united states preventive services task force recommendations and medicare coverage policies for preventive services in the United States

    May 1, 2013, 00:00

  • Reanalyzing Carotid Artery Stenosis Treatment Clinical Trial Results From A Bayesian Perspective

    May 1, 2013, 00:00

  • Using real-world claims data for planning oncology clinical trials

    May 1, 2013, 00:00

  • Electronic patient reported outcomes (epro)- The best defense in preventing missing pro data

    May 1, 2013, 00:00

  • Economic assessment of the prophylaxis versus on-demand approach for the treatment of hemophilia a in young patients in Mexico

    May 1, 2013, 00:00

  • Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India

    May 1, 2013, 00:00

  • Application of reclassification measures in comparing risk adjustment models

    May 1, 2013, 00:00

  • Effectiveness Of The Monovalent Rotavirus Vaccine In Colombia Through Different Analyses Within An Ecological Study

    May 1, 2013, 00:00

  • The Comparison Of The Use Of H2-Receptor Antagonists And Proton Pump Inhibitors Between Serbia And Scandinavian Countries

    May 1, 2013, 00:00

  • Markov models with different health-states for advanced breast cancer- A simulation study of lapatinb

    May 1, 2013, 00:00

  • How do pharmaceutical margins vary by region, therapeutic area and country gross domestic product?

    May 1, 2013, 00:00

  • Balloon Catheter Dilation For Chronic Rhinosinusitis Does Not Increase The Frequency Of Sinus Surgeries In The United States

    May 1, 2013, 00:00

  • Is between-mode equivalence comparable to test-retest reliability for patient-reported outcome (PRO) measures- A test case of web versus IVRS versus paper for the MSKCC bowel function instrument and LASA QOL

    May 1, 2013, 00:00

  • Cost-effectiveness of linezolid in the treatment of complicated skin and soft tissue infections (cssti) in chile – Private scenario

    May 1, 2013, 00:00

  • Medication Adherence And Cd4 Response In Patients Receiving Antiretroviral Therapy

    May 1, 2013, 00:00

  • Costs associated with breakthrough pain in cancer patients- findings from the national breakthrough pain survey

    May 1, 2013, 00:00

  • Impact of medicare part d- Comparison of health care expenditures and utilization for medicare patients with diabetes

    May 1, 2013, 00:00

  • Optimizing thresholds for a clinical recognition algorithm

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis In German Pharmaceutical Price Regulation

    May 1, 2013, 00:00

  • A Proportional Rule For Determining Ceiling Prices Of New Innovative Drugs

    May 1, 2013, 00:00

  • Adherence To Ada Hba1c Testing Frequency And Antidiabetic Therapy Guidelines Improves Patient Outcomes

    May 1, 2013, 00:00

  • Standard Treatment Cost Of Breast Cancer With Different Tnm Stage Among Western Chinese Women

    May 1, 2013, 00:00

  • Accounting for partial responders in cost-effectiveness modeling of biologics for psoriasis

    May 1, 2013, 00:00

  • Comparative safety and effectiveness of catheter ablation versus surgery for newly diagnosed atrial fibrillation

    May 1, 2013, 00:00

  • Patient preferences for attributes of disease modifying Therapies- Results of a choice based conjoint analysis

    May 1, 2013, 00:00

  • Ustekinumab Improves Arthritis-Related And Skin-Related Quality Of Life In Patients With Active Psoriatic Arthritis- Patient Reported Outcomes From Randomized And Double Blinded Phase Iii Psummit I Trial

    May 1, 2013, 00:00

  • Utilization of polypill for management of myocardial infarction

    May 1, 2013, 00:00

  • The Labor Productivity Effects Of Prostate Cancer Patients On Spouses And Other Family Members- Evidence From Us National Survey Data

    May 1, 2013, 00:00

  • Effect of L-carnitine on behavioral disorder in autistic children

    May 1, 2013, 00:00

  • Cost-effectiveness of lifestyle intervention among adults at a high risk for hypertension and diabetes- A health plan perspective

    May 1, 2013, 00:00

  • The Notion Of Representative Languages In The Context Of Translatability Assessment

    May 1, 2013, 00:00

  • Patients with nocturia – increasing time to first void improves sleep quality

    May 1, 2013, 00:00

  • Placebo effect sizes for patient reported outcomes in well-controlled drug trials- A 12-year systematic review

    May 1, 2013, 00:00

  • Comparative Direct And Indirect Costs Of Menorrhagia Treatment With Global Endometrial Ablation Or Hysterectomy

    May 1, 2013, 00:00

  • Cost And Effectiveness Of Antidepressants In The Hepatitis C Patients Treated With Interferon

    May 1, 2013, 00:00

  • Cost-effectiveness analysis of home haemodialysis for diabetes mellitus population in Taiwan

    May 1, 2013, 00:00

  • Race Differences In Walking Speed

    May 1, 2013, 00:00

  • Surveillance of cardiovascular risk factors among patients undergoing coronary artery bypass surgery

    May 1, 2013, 00:00

  • Risk And Cost-Effectiveness Analysis Of Adverse Atrial Fibrillation Outcome In Treating Osteoprosis

    May 1, 2013, 00:00

  • Economic Outcomes For Celecoxib In Latin America- A Cost-Effectiveness Study Of Cox-2 Inhibitors Against Nsaids+Ppi For Adult Patients With Osteoarthritis And Rheumatoid Arthritis In Brazil, Mexico, Colombia, Argentina And Costa Rica

    May 1, 2013, 00:00

  • Burden of acromegaly– A retrospective chart audit

    May 1, 2013, 00:00

  • Impact Of Vaccination Coverage On Cost-Effectiveness Of Influenza Vaccine At Preventing Hospitalization

    May 1, 2013, 00:00

  • Budget Impact Of Crizotinib For Alk-Positive Advanced Non-Small Cell Lung Cancer (Nsclc) In Colombia

    May 1, 2013, 00:00

  • The Role Of Geographical Proximity And Service Characteristics On Prompt Access To Health Care In Chps Setting In Rural Bawjiase Of Ghana

    May 1, 2013, 00:00

  • Medical and pharmacy claims-based algorithims for identifying patients with multiple sclerosis

    May 1, 2013, 00:00

  • Use Of Smoking Cessation Agents In Patients With Lung Cancer- An Exploratory Study

    May 1, 2013, 00:00

  • Analysis of 2011 medicaid fee-for-service outpatient drug utilization, expenditures and pharmacy reimbursement rates

    May 1, 2013, 00:00

  • Risk Of Death At One Year In Patients With Non-Small Cell Lung Cancer (Nsclc) Treated With Cisplatin Regimens- An Indirect Comparison Meta-Analysis Based On Renal Eligibility Criteria

    May 1, 2013, 00:00

  • Reviewing And Refining The Conceptual Framework For The Current Drug Development Paradigm (CDDP)

    May 1, 2013, 00:00

  • Impact Of Body Mass Index On Prognosis For Breast Cancer Patients

    May 1, 2013, 00:00

  • Acute care utilization in patients with epilepsy on antiepileptic monotherapy

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Switching To Insulin Aspart From Human Soluble Insulin In Chinese Patients With Type-2 Diabetes On A Basal-Bolus Regimen

    May 1, 2013, 00:00

  • Prevalence, Diagnosis Treatment Protocols For Breast Cancer In Southern Punjab

    May 1, 2013, 00:00

  • Distribution Outpatient Physiotherapy Services In The Different Trauma Diseases According To Major Body Parts In Hungary

    May 1, 2013, 00:00

  • Cost-effectiveness analyses for refractory overactive bladder- A systematic literature review

    May 1, 2013, 00:00

  • Racial variation in heart failure comorbidities and therapy use in a medicaid population

    May 1, 2013, 00:00

  • Colesevelam hcl or ezetimibe for hypercholesterolemia- differences in patient characteristics from a health care database

    May 1, 2013, 00:00

  • Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes

    May 1, 2013, 00:00

  • The Profile Of Solar Exposition And Use Of Sunscreening Agents Use Of Patients From São Paulo City With Actinic Keratosis (AK)

    May 1, 2013, 00:00

  • The 2012 Price Trend Analysis For 12 Leading Therapy Areas In 12 Selected Developed Adn Emerging Markets

    May 1, 2013, 00:00

  • Harmonization Of Health Technology Assessement And Regulatory Processes And Evidentiary Requirements For Drugs And Devices- Opportunities And Challenges

    May 1, 2013, 00:00

  • Patient-Reported Outcomes (Pros) Claims In Products Indicated For Treatment Of Non-Small-Cell Lung Carcinoma And Approved In Europe And In The United States

    May 1, 2013, 00:00

  • Nationwide Survey For Pharmacists On Patient Safety Culture In Japan

    May 1, 2013, 00:00

  • The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk

    May 1, 2013, 00:00

  • Analysis of consumption of antihypertensive drugs in Serbia in the period from 2006 to 2010 year

    May 1, 2013, 00:00

  • Comorbidities, Medications, Health Care Costs And Utilizations Of Veteran Patients With Gastroesophageal Reflux Disease In The United States

    May 1, 2013, 00:00

  • Incremental Health Care Resource Utilization Associated With Autosomal Dominant Polycystic Kidney Disease

    May 1, 2013, 00:00

  • Discrepancies Between Fda Approval And Cms Coverage For Drugs And Devices

    May 1, 2013, 00:00

  • Social Networks-Based Diabetes Education Improves Social Efficacy And Cohesion, And Favors Sustainability

    May 1, 2013, 00:00

  • The canard project (projet canard) cost-effectiveness analysis of real-world outcomes in a diabetic population- The impact of baseline characteristics in France

    May 1, 2013, 00:00

  • Cost-utility analysis of spinal cord stimulation in patient with failed back surgery syndrome- Results from the precise study

    May 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113 (current)
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »